115 related articles for article (PubMed ID: 38517408)
21. Regorafenib loaded self-assembled lipid-based nanocarrier for colorectal cancer treatment via lymphatic absorption.
Xia D; Hu C; Hou Y
Eur J Pharm Biopharm; 2023 Apr; 185():165-176. PubMed ID: 36870399
[TBL] [Abstract][Full Text] [Related]
22. Preparation of luteolin loaded nanostructured lipid carrier based gel and effect on psoriasis of mice.
Xu H; Hu H; Zhao M; Shi C; Zhang X
Drug Deliv Transl Res; 2024 Mar; 14(3):637-654. PubMed ID: 37695445
[TBL] [Abstract][Full Text] [Related]
23. Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities.
Khosroushahi AY; Naderi-Manesh H; Yeganeh H; Barar J; Omidi Y
J Nanobiotechnology; 2012 Jan; 10():2. PubMed ID: 22221539
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
25. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
[TBL] [Abstract][Full Text] [Related]
26. Thermosensitive
Hu Y; Chen X; Li Z; Zheng S; Cheng Y
J Biomed Nanotechnol; 2020 Jan; 16(1):54-64. PubMed ID: 31996285
[TBL] [Abstract][Full Text] [Related]
27. Integrated lecithin-bile salt nanovesicles as a promising approach for effective skin delivery of luteolin to improve UV-induced skin damage in Wistar Albino rats.
Abbas H; El Sayed NS; Ali ME; Elsheikh MA
Colloids Surf B Biointerfaces; 2022 Mar; 211():112299. PubMed ID: 34953364
[TBL] [Abstract][Full Text] [Related]
28. A rapid HPLC-MS/MS method for the simultaneous determination of luteolin, resveratrol and their metabolites in rat plasma and its application to pharmacokinetic interaction studies.
Wu W; Li K; Zhao C; Ran X; Zhang Y; Zhang T
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Feb; 1191():123118. PubMed ID: 35085987
[TBL] [Abstract][Full Text] [Related]
29. Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation.
Hatem S; El-Kayal M
Eur J Pharm Sci; 2023 Dec; 191():106612. PubMed ID: 37848153
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of epimedium fried with suet oil based on in vivo formation of self-assembled flavonoid compound nanomicelles.
Cui L; Sun E; Zhang ZH; Tan XB; Wei YJ; Jin X; Jia XB
Molecules; 2012 Nov; 17(11):12984-96. PubMed ID: 23117437
[TBL] [Abstract][Full Text] [Related]
31. Luteolin ameliorates cornea stromal collagen degradation and inflammatory damage in rats with corneal alkali burn.
Wang H; Guo Z; Liu P; Yang X; Li Y; Lin Y; Zhao X; Liu Y
Exp Eye Res; 2023 Jun; 231():109466. PubMed ID: 37059215
[TBL] [Abstract][Full Text] [Related]
32. Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability.
Zhao J; Li L; Wang Z; Li L; He M; Han S; Dong Y; Liu X; Zhao W; Ke Y; Wang C
Pharmacol Res; 2021 Dec; 174():105939. PubMed ID: 34655772
[TBL] [Abstract][Full Text] [Related]
33. Anti-Proliferative Potential of Cynaroside and Orientin-In Silico (DYRK2) and In Vitro (U87 and Caco-2) Studies.
Pirvu LC; Pintilie L; Albulescu A; Stefaniu A; Neagu G
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068880
[TBL] [Abstract][Full Text] [Related]
34. Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery.
Mandal A; Cholkar K; Khurana V; Shah A; Agrahari V; Bisht R; Pal D; Mitra AK
Mol Pharm; 2017 Jun; 14(6):2056-2069. PubMed ID: 28471177
[TBL] [Abstract][Full Text] [Related]
35. Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin.
Piazzini V; D'Ambrosio M; Luceri C; Cinci L; Landucci E; Bilia AR; Bergonzi MC
Molecules; 2019 Apr; 24(9):. PubMed ID: 31052197
[TBL] [Abstract][Full Text] [Related]
36. Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis.
Ashour AA; El-Kamel AH; Mehanna RA; Mourad G; Heikal LA
Drug Deliv; 2022 Dec; 29(1):3270-3280. PubMed ID: 36330597
[TBL] [Abstract][Full Text] [Related]
37. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
Joshi G; Kumar A; Sawant K
Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
[TBL] [Abstract][Full Text] [Related]
38. FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier.
Lu KY; Lin CW; Hsu CH; Ho YC; Chuang EY; Sung HW; Mi FL
ACS Appl Mater Interfaces; 2014 Oct; 6(20):18275-89. PubMed ID: 25260022
[TBL] [Abstract][Full Text] [Related]
39. Effects of ultrasonic pretreatment of soybean protein isolate on the binding efficiency, structural changes, and bioavailability of a protein-luteolin nanodelivery system.
Sun F; Li B; Guo Y; Wang Y; Cheng T; Yang Q; Liu J; Fan Z; Guo Z; Wang Z
Ultrason Sonochem; 2022 Aug; 88():106075. PubMed ID: 35753139
[TBL] [Abstract][Full Text] [Related]
40. Development and Evaluations of Transdermally Delivered Luteolin Loaded Cationic Nanoemulsion: In Vitro and Ex Vivo Evaluations.
Altamimi MA; Hussain A; Alshehri S; Imam SS; Alnemer UA
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
